These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 2102726

  • 1. [Hemolytic anemia and alphamethyldopa].
    Ronda Gasulla A, Sospedra Lara EM, Calvo Catala J, González Pérez JA, Godoy Rocati D.
    An Med Interna; 1990 May; 7(5):275. PubMed ID: 2102726
    [No Abstract] [Full Text] [Related]

  • 2. [Chronic hemolytic anemia due to alphamethyldopa. Immunologic mechanism].
    Perreau P, Gardais J, Anjuere J, Guimbretière J.
    Presse Med (1893); 1969 Nov 22; 77(49):1821-2. PubMed ID: 4189111
    [No Abstract] [Full Text] [Related]

  • 3. [Hemolytic anemia due to alpha-methyldopa].
    Kaplinsky N, Fraenkel O.
    Harefuah; 1972 Dec 01; 83(11):487-8. PubMed ID: 4669519
    [No Abstract] [Full Text] [Related]

  • 4. Drug induced hemolytic anemia.
    Lobell M, Woodburn R.
    Minn Med; 1975 Mar 01; 58(3):239-43. PubMed ID: 1113723
    [No Abstract] [Full Text] [Related]

  • 5. [Alpha methyldopa causing hemolytic anemia].
    Brubakk O.
    Tidsskr Nor Laegeforen; 1973 Dec 30; 93(35):2570-1. PubMed ID: 4772806
    [No Abstract] [Full Text] [Related]

  • 6. [Hemolytic anemia following methyldopa].
    Hallak A, Yust I, Rotmertsch HH, Liron Y.
    Harefuah; 1982 Feb 01; 102(3):97-8. PubMed ID: 7106642
    [No Abstract] [Full Text] [Related]

  • 7. [Coombs-positive hemolytic anemia induced by alpha-methyldopa (Aldomet) therapy].
    Kariya T, Kamakura S, Konuma S, Oashi T, Masuyama Y.
    Rinsho Ketsueki; 1973 Jul 01; 14(7):749-56. PubMed ID: 4738829
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Methyldopa, hemolytic anemia and acute leukemia.
    Boone AW, Carey RW.
    J Maine Med Assoc; 1971 Dec 01; 62(12):289. PubMed ID: 5288729
    [No Abstract] [Full Text] [Related]

  • 11. [A case of alpha-methyldopa-induced hemolytic anemia with cholestasis (author's transl)].
    Sakamaki H, Dan K, Onozawa Y, Adachi Y, Ukishima H.
    Rinsho Ketsueki; 1977 Jun 01; 18(6):821-7. PubMed ID: 916211
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acquired hemolytic anemia with unusual serological characteristics probably caused by alpha-methyldopa.
    Robinson S.
    Can J Med Technol; 1970 Oct 01; 32(5):188-95. PubMed ID: 5480713
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatitis and hemolytic anemia associated with methyldopa therapy.
    Breland BD, Hicks GS.
    Drug Intell Clin Pharm; 1982 Jun 01; 16(6):489-92. PubMed ID: 7094845
    [Abstract] [Full Text] [Related]

  • 18. Methyldopa-induced immune hemolytic anemia and chronic active hepatitis.
    Shalev O, Mosseri M, Ariel I, Stalnikowicz R.
    Arch Intern Med; 1983 Mar 01; 143(3):592-3. PubMed ID: 6830396
    [Abstract] [Full Text] [Related]

  • 19. [Acquired hemolytic anemia. Rare examples of a rare group of diseases].
    Bucher U, Kummer H, Batz K.
    Praxis; 1969 Mar 25; 58(12):355-64. PubMed ID: 5818674
    [No Abstract] [Full Text] [Related]

  • 20. Acquired haemolytic anaemia. II. Drug-induced haemolytic anaemia.
    Böttiger LE, Westerholm B.
    Acta Med Scand; 1973 Mar 25; 193(3):227-31. PubMed ID: 4693788
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.